World Library  
Flag as Inappropriate
Email this Article

2-Diphenylmethylpyrrolidine

Article Id: WHEBN0024384139
Reproduction Date:

Title: 2-Diphenylmethylpyrrolidine  
Author: World Heritage Encyclopedia
Language: English
Subject: Pipradrol, Diphenylpyraline, Desoxypipradrol, Diphenylprolinol, Designer drugs
Collection: Designer Drugs, Pyrrolidines, Stimulants
Publisher: World Heritage Encyclopedia
Publication
Date:
 

2-Diphenylmethylpyrrolidine

2-Diphenylmethylpyrrolidine
Systematic (IUPAC) name
(RS)-2-(Diphenylmethyl)pyrrolidine
Identifiers
CAS Registry Number  N
PubChem CID:
ChemSpider  YesY
Chemical data
Formula C17H19N
Molecular mass 237.339
 N   

2-Diphenylmethylpyrrolidine (Desoxy-D2PM), also known as 2-benzhydrylpyrrolidine, is a stimulant psychoactive drug. It is the 4-dehydroxylated structural analog of diphenylprolinol (D2PM), and is also similar in structure to desoxypipradrol (2-DPMP), both of which act as norepinephrine-dopamine reuptake inhibitors (NDRIs). Like D2PM and 2-DPMP, Desoxy-D2PM is sold as a designer drug and has been used in the manufacture of legal highs. It has been marketed under the names A3A New Generation, A3A Methano, and Green Powder, and has been reported to cause hallucinations, violent behavior, dilated pupils, tachycardia, and high blood pressure.[1][2][3] Literature data suggest a high risk of central nervous and cardiovascular system toxicity.[4]

Desoxy-D2PM has two enantiomers which are used industrially in their purified form as chiral derivatizing agents during chemical synthesis.[5]

As of 4 November 2010, the UK Home Office announced a ban on the importation of 2-diphenylmethylpyrrolidine, following a recommendation from the ACMD.[6] It was due to become a class B drug[7] on 28 March 2012,[8] but the bill was scrapped, due to the presence of two steroids included in the bill that were later recommended to remain uncontrolled.[9]

It was made a class B drug and placed in Schedule I on 13 June 2012.[10]

References

  1. ^
  2. ^
  3. ^
  4. ^
  5. ^
  6. ^ Import ban on psychoactive drug, UK Home Office
  7. ^
  8. ^
  9. ^
  10. ^


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.